rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    OMER
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Omeros: Yartemlea Commercial Momentum Supports Upgrade Despite Q3 Deceleration (Rating Upgrade)
      14h agoSeeking AlphaOMER
      Omeros (OMER) Just Gave Investors Another Reason to Sell
      21h agoYahoo FinanceOMER
      Why Is Omeros Stock Trading Lower Tuesday?
      Nov 17BenzingaOMER
      Red Cat Downbeat Q3 Results, Joins Omeros, Deutsche Bank And Other Big Stocks Moving Lower In Tuesday’s P
      Nov 17BenzingaOMERRCATDB
      Omeros Q3 Earnings Call Highlights
      Nov 17Yahoo FinanceOMER
      Why is Omeros stock sliding today?
      Nov 16Investing.comOMER
      Omeros Corporation to Announce Third Quarter Financial Results on November 16, 2026
      Nov 10Yahoo FinanceOMER
      Omeros earnings on deck: Can Yartemlea sales sustain momentum?
      Nov 10Investing.comOMER
      Omeros: The Trade After European Rejection (NASDAQ:OMER)

      Omeros Corporation is positioned to dominate the TM-TMA market with Yartemlea, the only FDA-approved therapy for this indication. See why I rate OMER stock a hold.

      Oct 21Seeking AlphaOMER
      Update: Omeros Shares Fall After Narsoplimab Application Rejected Again by EU Agency
      Oct 16Yahoo FinanceOMER
      European regulators reject Omeros’ TA-TMA treatment application
      Oct 16Investing.comOMER
      Omeros Shares Fall 4% as European Regulators Uphold Negative Opinion on Narsoplimab
      Oct 16Yahoo FinanceOMER
      Omeros Faces Second Rejection Of Narsoplimab In Europe – OMER Stock Falls Below Key Support For First Time In Nearly 3 Months
      Oct 16Yahoo FinanceOMER
      Why is Omeros stock sliding today?
      Oct 16Investing.comOMER
      Omeros shares slide following European regulatory setback for Narsoplimab
      Oct 16Investing.comOMER
      Omeros Stock Sinks on Negative EU Opinion for Narsoplimab, Compassionate-Use Program Ends
      Oct 16BenzingaOMER
      Omeros Corporation Receives CHMP Negative Opinion Following Re-Examination of European Marketing Authorization Application for Narsoplimab in TA-TMA
      Oct 16Yahoo FinanceOMER
      Omeros Shares Slide After CHMP Upholds Negative Opinion On Drug; Analyst Sees Buying Opportunity At $16
      Oct 16Yahoo FinanceOMER
      Cantor Fitzgerald reiterates Omeros stock Overweight rating ahead of CHMP
      Oct 14Investing.comOMER
      Omeros VP finance David Borges sells $419,000 in shares
      Sep 25Investing.comOMER
      Omeros Transplant Drug Could Be Bigger than Expected, Says Analyst - Omeros (NASDAQ:OMER)

      Cantor upgrades Omeros to Overweight with a $22 price forecast following strong Yartemlea sales and Medicare reimbursement momentum.

      Sep 22BenzingaOMER
      Omeros stock upgraded at Cantor Fitzgerald (OMER:NASDAQ)
      Sep 22Seeking AlphaOMER
      Cantor Fitzgerald upgrades Omeros stock rating on Yartemlea launch
      Sep 22Investing.comOMER
      Omeros Corporation stock hits 52-week high at 19.75 USD
      Sep 22Investing.comOMER
      This Plexus Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
      Sep 22BenzingaOMERPLXSMET
      Omeros VP, finance & CAO David Borges sells $206,804 in shares
      Sep 1Investing.comOMER
      Omeros Insider Sold Shares Worth $929,668, According to a Recent SEC Filing
      Sep 1Yahoo FinanceOMER
      What Makes Omeros (OMER) a Strong Momentum Stock: Buy Now?

      Does Omeros (OMER) have what it takes to be a top stock pick for momentum investors? Let's find out.

      Aug 28Yahoo FinanceOMER
      Omeros Insider Sold Shares Worth $282,094, According to a Recent SEC Filing

      Arnold C Hanish, Director, on August 26, 2026, sold 15,000 shares in Omeros (OMER) for $282,094. Fol

      Aug 28Yahoo FinanceOMER
      Omeros VP of finance David Borges sells $206,804 in shares
      Aug 25Investing.comOMER
      Omeros (OMER) Just Flashed Golden Cross Signal: Do You Buy?

      Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?

      Aug 25Yahoo FinanceOMER
      Omeros director Thomas Cable sells $276,772 in company stock
      Aug 21Investing.comOMER
      Omeros Insider Sold Shares Worth $276,773, According to a Recent SEC Filing

      Thomas J. Cable, Director, on August 20, 2026, sold 15,000 shares in Omeros (OMER) for $276,773. Fol

      Aug 21Yahoo FinanceOMER

      This is the newest page. Registered accounts read further back.